Muyi Yang
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 17, 2025
POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers.
Journal: Acta oncologica (Stockholm, Sweden)
Published: June 03, 2025
Germline MC1R Variant Status and Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Melanoma.
Journal: Pigment cell & melanoma research
Published: May 30, 2025
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 31, 2022
Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: May 05, 2021
Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 15, 2021
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Journal: Scientific reports
Published: March 12, 2019
PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Journal: Cancer research
Published: January 17, 2017
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility.
Journal: Genes, chromosomes & cancer
Published: December 18, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026